长沙招聘

Major Accountabilities (Describe the main results of the job to be achieved )
KOL/Speaker Management
- Contribute to identification/ mapping of KOLs .
- Develop professional relationships with the targeting KOLs and build ad-vocacy and gain contributions of KOL/decision makers .
- Track, analyze and reports targeting KOLs advocacy, contribution and publication status in required system and KOL management tool as ap-propriate.
- Provide and discuss scientific information and data regarding to Brands pipeline to healthcare professionals to ensure quality and accuracy of key medical and scientific information on new treatment options by face to face visiting, speaker training and scientific communications.
- Scientific support of speaker training activities in GCPO with timely feed-back and manage unsolicited requests /objections comply with NP4 and China legal and regulatory requirements.

Meeting/Events
- Main function as the Novartis medical speaker to present at Novar-tis/Society sponsored activities for up-to-date data based scientific and clinical information on Novartis product(s).
- Liaise and provide up-to-date medical support to facilitate listing of prod-ucts in medical guidelines, RDL, formularies as appropriate.
- Participate in cross functional meetings as appropriate and sharing feed-back of targeting KOLs advocacy and contribution.
- Tailor and adapt speaker slides in alignment with NP4 and GCR Brand strategies.

Clinical trials/Studies
- Contribute to the identification and recommendation of appropriate KOL involvements and participants in Novartis sponsored clinical tri-als(PMS,Phase III and Phase IV studies) from GCPO.
- Conduct or Coordinate third party trials/animal studies/Registry pro-grams/research fund raised and funded by GCPO as a KOL development tools to build advocate and partnership.

Field Force Therapeutic Training
- Provide basic therapeutic training and refresher training to sales reps with GCPO sales operations..
- May function as an internal scientific trainer at GCPO meetings.

Ideal Background (State the minimum and desirable education and experience
Education:
Clinical bachelor degree or higher (preferable with 2 yrs of clinical practice experience).
Required: Be considered as a peer of the customer base. MD, PharmD, Pharmacist, PHD and other life sciences with solid medical/technical background and proven competencies influencing skills, clinical research insight, business and market knowledge.

Experience:
1. Proven ability to develop and foster peer-to-peer, credible relationships in order to educate and influence KOL/decision makers.
2. Working knowledge of the Healthcare System and of the research procedures as well as the ICH guidelines, GCP and other ethical guidelines relevant to the pharmaceutical indus-try.
3. Thorough knowledge of clinical medicine, disease man-agement, and medical research in at least one therapeutic area.
4. Ability to synthesize recent scientific information ,analyze within strategic and regulatory
settings.
5. Proven ability to use IT tools and interface effectively with a variety of technical platforms.
6. Strong personal integrity, and customer focus.
7. Excellent interpersonal communication, negotiation and advanced presentation skills.
8. Effectively contribute to multifunctional teams.
9. Must be able to adapt, organize, prioritize, and work effec-tively in a constantly changing field based environment.

Languages:
Fluent in Chinese and English (oral and written)

1. Job Purpose (State in one sentence the overall objective of the job)
-To work within the ICRO function to develop clinical trial nprotocols, assist in the selection of study sites and write study reports for key clinical trials in asociation with inputs from marketing, Key Opinion Leaders and ICRO members

2. Major Accountabilities (Describe the main results of the job to be achieved) -----Select research centers and principle investigators' and co-investigators' name list for registration clinical trial, discuss clinical trial protocol and obtain approvals from headquarters
- Attend the regular meetings of the clinical study [including teleconferences, investigator meetings and monthly ICRO meetings]
- Follow and be familiar with the progress of the study and feedback from the investigators concerning trial conduct and the product.
- As the bridge between the market and ICRO, actively assist ICRO to perform Phase II/III and IV A clinical research
- Be familiar with the company's new product's characteristics, understand the products' research development and communicate with relevant professionals regularly;
- Based on local marketing requirement, academic value and ICRO resource, review and discuss clinical research solutions with ICRO;
- Answer medical questions on new products raised by medical academic area;
- Offer medical support for other departments, e.g. the Registration Department or GP&A Department.
3. Ideal Background (State the minimum and desirable education and experience level)
-Education: University degree (minimum), major in clinical research or medical, postgraduate degree and overseas experience is strongly preferred
-Languages: Good in English writing, reading, speaking and listening skills
-Experience: 5 years clinical research experience in pharmaceutical industry, understand current medical practice
Specific Professional Competencies: Indicate any other soft/technical/professional knowledge and skills requirements
- Significant experience in protocol development and study report writing.
- Detail oriented with strong analytical capability;
- Strong communication and persuasive skills;
- Good contact with external medical academic professionals;
- Strong Sense of responsibility and dedication;
- Teamwork spirit

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。